DOCUSATE for Psoriasis: Side Effects & Safety Data
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
There are 9 adverse event reports in the FDA FAERS database where DOCUSATE was used for Psoriasis.
Most Reported Side Effects for DOCUSATE
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Somnolence | 514 | 19.6% | 105 | 428 |
| Gastrooesophageal reflux disease | 419 | 16.0% | 12 | 325 |
| Pneumonia aspiration | 341 | 13.0% | 5 | 325 |
| Coma | 337 | 12.9% | 1 | 323 |
| Constipation | 329 | 12.6% | 90 | 183 |
| Drug ineffective | 288 | 11.0% | 47 | 95 |
| Dyspnoea | 277 | 10.6% | 59 | 179 |
| Off label use | 236 | 9.0% | 93 | 161 |
| Vomiting | 207 | 7.9% | 92 | 165 |
| Pain | 195 | 7.4% | 20 | 127 |
| Nausea | 190 | 7.3% | 92 | 122 |
| Diarrhoea | 185 | 7.1% | 12 | 87 |
| Pulmonary embolism | 170 | 6.5% | 68 | 117 |
| Toxicity to various agents | 158 | 6.0% | 72 | 83 |
| Product use in unapproved indication | 142 | 5.4% | 50 | 91 |
Other Indications for DOCUSATE
Product used for unknown indication (1,476)
Constipation (470)
Faeces hard (33)
Pain (29)
Foetal exposure during pregnancy (18)
Maternal exposure timing unspecified (14)
Gastrointestinal disorder (12)
Laxative supportive care (11)
Migraine (9)
Constipation prophylaxis (7)
Other Drugs Used for Psoriasis
APREMILAST (76,127)
SECUKINUMAB (58,471)
ADALIMUMAB (56,634)
RISANKIZUMAB-RZAA (40,890)
ETANERCEPT (30,483)
USTEKINUMAB (21,763)
IXEKIZUMAB (16,569)
GUSELKUMAB (11,736)
CERTOLIZUMAB PEGOL (8,179)
METHOTREXATE (6,628)